Aterian (ATER) Projected to Post Quarterly Earnings on Thursday

Aterian (NASDAQ:ATERGet Free Report) is anticipated to post its Q2 2026 results before the market opens on Thursday, August 13th. Analysts expect Aterian to post earnings of ($0.17) per share and revenue of $20.3050 million for the quarter. Individuals can check the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 19, 2026 at 5:00 PM ET.

Aterian (NASDAQ:ATERGet Free Report) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.39) EPS for the quarter, beating analysts’ consensus estimates of ($0.69) by $0.30. The business had revenue of $0.02 million during the quarter, compared to analysts’ expectations of $15.82 million. Aterian had a negative net margin of 39.56% and a negative return on equity of 82.05%.

Aterian Trading Up 1.9%

Shares of Aterian stock opened at $0.49 on Wednesday. The stock’s fifty day simple moving average is $1.00 and its 200 day simple moving average is $0.85. The company has a market capitalization of $5.32 million, a PE ratio of -0.19 and a beta of 0.78. Aterian has a 12 month low of $0.35 and a 12 month high of $1.87.

Institutional Investors Weigh In On Aterian

Several large investors have recently made changes to their positions in the stock. Citadel Advisors LLC raised its holdings in shares of Aterian by 222.0% during the third quarter. Citadel Advisors LLC now owns 33,165 shares of the company’s stock worth $35,000 after acquiring an additional 22,865 shares during the period. Susquehanna International Group LLP boosted its stake in Aterian by 310.2% in the 3rd quarter. Susquehanna International Group LLP now owns 40,512 shares of the company’s stock worth $43,000 after purchasing an additional 30,637 shares during the period. Goldman Sachs Group Inc. boosted its stake in Aterian by 73.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 21,392 shares of the company’s stock worth $45,000 after purchasing an additional 9,026 shares during the period. Finally, XTX Topco Ltd bought a new position in Aterian during the 2nd quarter worth about $55,000. Institutional investors own 7.02% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on ATER shares. Wall Street Zen downgraded Aterian from a “hold” rating to a “sell” rating in a report on Saturday, July 25th. Weiss Ratings upgraded Aterian from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 19th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has an average rating of “Sell”.

Get Our Latest Report on ATER

About Aterian

(Get Free Report)

Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.

Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.

Featured Stories

Earnings History for Aterian (NASDAQ:ATER)

Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.